Pfizer’s former CEO and CFO relayed proposals from activist investor Starboard Value to several members of the company’s board on Sunday, according to a source …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
iTeos Therapeutics will set aside inupadenant following lackluster mid-stage data in non-small cell lung cancer. The company will focus on its TIGIT therapies instead, with
PHILADELPHIA — A systolic blood pressure treatment target under 120 mm Hg improved outcomes and saved lives compared with a threshold of 140 mm Hg
Despite being the largest minority in the nation, disabled people like us have been structurally and institutionally obstructed from entering research-dominated fields. When they do